Liang Liu

A2AR Antagonism with CPI-444 Induces Antitumor Responses and Augments Efficacy to Anti–PD-(L)1 and Anti–CTLA-4 in Preclinical Models

Stephen B. Willingham, Po Y. Ho, Andrew Hotson et al. · Cancer Immunology Research · 2018 · 209 citations

Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer

Zebo Jiang, Wenjun Wang, Cong Xu et al. · Cancer Letters · 2021 · 207 citations

Derivative Apigenin, Medicine, Oncogenic Agent +10

Genistein depletes telomerase activity through cross‐talk between genetic and epigenetic mechanisms

Yuanyuan Li, Liang Liu, Lucy G. Andrews et al. · International Journal of Cancer · 2009 · 191 citations · Full text

Natural Isoflavone, Genetics, Telomerase Activity +22

Dissecting intratumoral myeloid cell plasticity by single cell RNA‐seq

Qianqian Song, Gregory A. Hawkins, L. James Wudel et al. · Cancer Medicine · 2019 · 169 citations · Full text

Immunology, Gene Expression Traits, Cancer Biology +16

The phosphatase DUSP2 controls the activity of the transcription activator STAT3 and regulates TH17 differentiation

Dan Lü, Liang Liu, Xin Ji et al. · Nature Immunology · 2015 · 153 citations

Transcriptional Regulation, Systems Biology, Signal Transduction +14